The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical prognostic factors and genomic analysis of ovary metastases (mets) from colorectal cancer (CRC).
 
Karuna Ganesh
No Relationships to Disclose
 
Ronak Shah
No Relationships to Disclose
 
Efsevia Vakiani
No Relationships to Disclose
 
Nancy E. Kemeny
No Relationships to Disclose
 
Anne Lincoln
No Relationships to Disclose
 
Christina Tran
No Relationships to Disclose
 
Anna M. Varghese
No Relationships to Disclose
 
Rona D. Yaeger
No Relationships to Disclose
 
Andrea Cercek
Consulting or Advisory Role - Baxter; Bayer
Research Funding - Bayer
 
Neil Howard Segal
Honoraria - MedImmune
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Imugene; Macrogenics; Pfizer
Research Funding - Bristol-Myers Squibb; MedImmune; Pfizer; Roche/Genentech
 
Diane Lauren Reidy
Honoraria - Novartis
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Research Funding - Novartis
 
Andrew S. Epstein
No Relationships to Disclose
 
Martin R. Weiser
No Relationships to Disclose
 
Julio Garcia-Aguilar
No Relationships to Disclose
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics
 
Leonard Saltz
Consulting or Advisory Role - Abbvie; Lilly; McNeil PPC (I); Roche/Genentech
Research Funding - Taiho Pharmaceutical
 
Zsofia Kinga Stadler
Stock and Other Ownership Interests - Alimera Sciences (I); Avalanche Biotechnologies (I)
Consulting or Advisory Role - Alimera Sciences (I); Allergan (I); Avalanche Biotechnologies (I); Bausch and Lomb (I); Genentech/Roche (I); Optos (I); Regeneron (I)